{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:12:48Z","timestamp":1792761168028,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["Dnr 2020-02445"],"award-info":[{"award-number":["Dnr 2020-02445"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To conduct the first-ever nationwide, population-based cohort study investigating survival patterns of all patients with incident SSc in Sweden compared with matched individuals from the Swedish general population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used the National Patient Register to identify patients with incident SSc diagnosed between 2004 and 2015 and the Total Population Register to identify comparators (1:5), matched on sex, birth year and residential area. We followed them until death, emigration or the end of 2016. Follow-up of the general population comparators started the same date as their matched patients were included. We estimated all-cause survival using the Kaplan\u2013Meier method, crude mortality rates and hazard ratios (HRs) using flexible parametric models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 1139 incident patients with SSc and 5613 matched comparators. The median follow-up was 5.0\u2009years in patients with SSc and 6.0\u2009years for their comparators. During follow-up, 268 deaths occurred in patients with SSc and 554 in their comparators. The 5-year survival was 79.8% and the 10-year survival was 67.7% among patients with SSc vs 92.9% and 84.8%, respectively, for the comparators (P\u2009&amp;lt;\u20090.0001). The mortality rate in patients with SSc was 42.1 per 1000 person-years and 15.8 per 1000 person-years in their comparators, corresponding to an HR of 3.7 (95% CI 2.9, 4.7) at the end of the first year of follow-up and 2.0 (95% CI 1.4, 2.8) at the end of the follow-up period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Despite advances in understanding the disease and in diagnostic methods over the past decades, survival is still severely impacted in Swedish patients diagnosed with SSc between 2004 and 2015.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keac474","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T13:18:14Z","timestamp":1660915094000},"page":"1170-1178","source":"Crossref","is-referenced-by-count":8,"title":["Survival in Swedish patients with systemic sclerosis: a nationwide population-based matched cohort study"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6269-2792","authenticated-orcid":false,"given":"Majd","family":"Bairkdar","sequence":"first","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Medicine, Solna"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enoch Yi-Tung","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W","family":"Dickman","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Hesselstrand","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Section for Rheumatology, Lund University and Sk\u00e5ne University Hospital , Lund"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3380-5342","authenticated-orcid":false,"given":"Helga","family":"Westerlind","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Medicine, Solna"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8996-5260","authenticated-orcid":false,"given":"Marie","family":"Holmqvist","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Medicine, Solna"},{"name":"Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0000000000000027","article-title":"Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies","volume":"26","author":"Nikpour","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"102494","DOI":"10.1016\/j.autrev.2020.102494","article-title":"Gender-related differences in systemic sclerosis","volume":"19","author":"Hughes","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2023030119163295700_","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2023030119163295700_","first-page":"1573","article-title":"Jr. Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-118-8-199304150-00005","article-title":"Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis)","volume":"118","author":"Bulpitt","year":"1993","journal-title":"Ann Intern Med"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3899\/jrheum.121390","article-title":"Survival and causes of death in an unselected, and complete cohort of Norwegian patients with systemic sclerosis","volume":"40","author":"Hoffmann-Vold","year":"2013","journal-title":"J Rheumatol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-019-1867-1","article-title":"Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature","volume":"21","author":"Pokeerbux","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.semarthrit.2008.06.002","article-title":"Determinants of morbidity and mortality of systemic sclerosis in Canada","volume":"39","author":"Al-Dhaher","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.57.11.682","article-title":"Mortality and causes of death in a Swedish series of systemic sclerosis patients","volume":"57","author":"Hesselstrand","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"2023030119163295700_","volume-title":"Patientregistret","author":"Socialstyrelsen","year":"2018"},{"key":"2023030119163295700_","volume-title":"L\u00e4karbemanning 2002\u20132020","author":"F\u00f6rening","year":"2020"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/BOR.0000000000000551","article-title":"Mortality and survival in systemic sclerosis: a review of recent literature","volume":"30","author":"Poudel","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"2023030119163295700_","author":"Organisation for Economic Co-operation and Development"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1378\/chest.130.1.176","article-title":"Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma","volume":"130","author":"Alkotob","year":"2006","journal-title":"Chest"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1445-5994.2006.01138.x","article-title":"Scleroderma: it has been a long hard journey","volume":"36","author":"Roberts-Thomson","year":"2006","journal-title":"Intern Med J"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ncprheum0268","article-title":"Therapy insight: the recognition and treatment of retinal manifestations of systemic vasculitis","volume":"2","author":"Aristodemou","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2023030119163295700_","first-page":"382","article-title":"Prevalence of sicca symptoms and Sjogren\u2019s syndrome in systemic sclerosis: results of a prospective two-center series of 133 patients","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2023030119163295700_","first-page":"515","article-title":"Erosive symmetric polyarthritis in scleroderma patients are characterized by an increased prevalence of antiCCP but not of rheumatoid factor","volume":"65","author":"Mancarella","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3899\/jrheum.111582","article-title":"Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients","volume":"39","author":"Sampaio-Barros","year":"2012","journal-title":"J Rheumatol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.semarthrit.2004.09.001","article-title":"Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002","volume":"34","author":"Alamanos","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.066340","article-title":"Survival and causes of death in 366 Hungarian patients with systemic sclerosis","volume":"67","author":"Czirjak","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3899\/jrheum.100298","article-title":"Predictors of survival and causes of death in Japanese patients with systemic sclerosis","volume":"38","author":"Hashimoto","year":"2011","journal-title":"J Rheumatol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pathophys.2019.05.003","article-title":"Scleroderma: an insight into causes, pathogenesis and treatment strategies","volume":"26","author":"Singh","year":"2019","journal-title":"Pathophysiology"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.24284","article-title":"Time to diagnosis in systemic sclerosis: is sex a factor?","volume":"61","author":"Hudson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1007\/s10067-018-4291-z","article-title":"Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study","volume":"37","author":"Li","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00296-017-3826-y","article-title":"Determinants of mortality in systemic sclerosis: a focused review","volume":"38","author":"Poudel","year":"2018","journal-title":"Rheumatol Int"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/1756-185X.13111","article-title":"Mortality in the Waikato Hospital Systemic Sclerosis Cohort","volume":"21","author":"Ooi","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1445-5994.2010.02281.x","article-title":"Survival in scleroderma: results from the population-based South Australian Register","volume":"41","author":"Hissaria","year":"2011","journal-title":"Intern Med J"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jclinepi.2009.01.010","article-title":"Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995","volume":"62","author":"Johansson","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/03009742.2011.553736","article-title":"Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan","volume":"40","author":"Kuo","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s10067-013-2289-0","article-title":"Mortality in systemic sclerosis-a single centre study from the UK","volume":"32","author":"Strickland","year":"2013","journal-title":"Clin Rheumatol"},{"key":"2023030119163295700_","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MD.0b013e318189372f","article-title":"Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study","volume":"87","author":"Arias-Nunez","year":"2008","journal-title":"Medicine"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac474\/45751149\/keac474.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/3\/1170\/49355973\/keac474.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/3\/1170\/49355973\/keac474.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T23:21:01Z","timestamp":1700954461000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/3\/1170\/6671863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,8,19]]},"published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac474","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2022,8,19]]}}}